Biopharmaceutical Company Confirms Arbitration Award of $3,059,998

FSD Pharma, Inc., a biopharmaceutical company known for its dedication to the development of innovative treatments for neurodegenerative and metabolic disorders as well as alcohol misuse disorders, recently emerged victorious in a legal battle against Dr. Raza Bokhari. On June 27, 2024, the United States District Court for the Eastern District of Pennsylvania confirmed a motion for entry of judgment, marking the end of what has been a contentious period for both parties involved. The ruling was made in favor of FSD Pharma, requiring Dr. Raza Bokhari to pay several sums amounting to a total of $3,059,998 plus accrued interest. $FSD Pharma(HUGE.US)$